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Diamidc (azodicarbosylic acid bis(dimcthyl;tmidc)) inhibits protein tyrosins phosphatasc activity in librobktsts without altering protein lyrosine 
kinusc nctivity associated with the cpidcrmal growth factor rcccptor. The loss of protein tyrosinc phosphutusauctivity CitusCd by diamidc is rcvcrscd 
by 2-mcrcapto~tlmnol or cpidcrmal growth factor. 
EGF receptor: Protein tyrosine pl~osplu~~asc: Oxidation-reduction 
1. INTRODUCTION 
Epiclermnl growth factor (EGF) binds to its cell sur- 
face receptor containing tyrosine kinase activity. The 
activation of the tyrosine kinase activity by the binding 
process triggers a cascade of events that transduces a 
signal from the cell surface to the nucleus [l]. Receptor 
tyrosine kinases catalyse the phosphorylation of tyro- 
sine residues either on their own polypeptide chain or 
on numerous intrinsic substrates in the signal pathway 
121. Recent evidence suggests that tyrosine kinase phos- 
phorylation could be regulated by a diverse family of 
enzymes referred to as protein tyrosine phosphatases 
(PT-Pax) [3,4], whose catalytic activity is dependent on 
a specific cysteine residue [5]. PTPase activity is found 
associated with the plasma membrane and/or in the 
cytosol [6]. Their specific activities are much greater 
than protein tyrosine kinases .xrd they therefore have 
thecapacity to regulate the levei of tyrosine phosphoryl- 
ation of proteins involved in signal transduction path- 
ways in the cell [7]. 
2. MATERIALS AND METI-iODS 
EGF from mouse submaxillary glauds wus obtained from Toyobo 
Co. EIcctrophorcsis rcugcnts L... 1’np* from Bio-R;td. Dinmidc ;tr,d ull 
other chemicals \‘r’erc of rcagcnt grttdc :rnd wcrc from Sigma. A mono- 
clonul antibody specific for the human EGF rcccptor (Immunoglobin 
Ahbrc~i~rriorrs: EGF. cpidcrmttl growth fuctor; PTPasc. protcitl tyro- 
sine pltosphutttsc; DMEM, Dttlbccco’s modilicd Eagle’s medium; 
SDS. sodiunl dodccyl sulfm. 
*fwrrarrcrrr ddrc.s.s: Funduclo Hcmoccntro dc S. Paulo. S. Pnulo. 
Bruzil. 
CfJJ’f?~/JUJll/LVlrL! ndrhw: Arnold Slcrn, Dcpurtmcnt of Ph;trmttcology. 
NW York University Medical Ccntcr. 550 First Avcnuc, NW York, 
NY 10016, USA. Fux: (I) (212) 263 7133. 
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G 108. I) wus provided by Dr. Francoisc Bcllot (Row Central 
Rcscurch. King of Prussiu. PA). Affinity-purilicd antiphosphotyrosine 
untibodics wcrc u gih of Dr. Ben Margolis (NYU Medical Ccntcr. 
NY). NIH- 3T3 cells cxprcssing the human EGF rcccptor (HER I4 
cells) [8] wcrc grown in Dulbccco’s modilied Euglc’s medium 
(DMEM) supplcmcntcd with lOJo c’ fetal bovine serum. in IOO-mm 
plastic culture dishes. Incubations wcrc done in DMEM conmining 
20 mM HEPES und I% bovine serum albumin ut 25°C. After incuba- 
tion. cells wcrc solubilizcd in lysis buffer A (20 mM HEPES, pH 7.5. 
I SO mM NaCI. 10% g!yfcrol. I% Triton X-100. I .S mM MgC12. I tnM 
EGTA. I fig/ml aprotmm, I ~.g/ml leupcptin uud I mM phcnylmcthyl- 
sulfonyltluoridc). After 30 min incubation 011 ice. lysmcs wcrc spun- 
down for IO min al 4OC us IZ 000 x g. The supwwtunts wcrc collcctcd 
and scrvcd as the source of PTPase activity. PTPnsc activity was 
essayed by mixing 100 ~1 of cdl Iysate, 7 :!~!t!i H s?ispcnsion conlilinitu3 
immunoprccipituted rJP]-lubclcd EGF rcc:ptors, prepared csscntially 
us dcscribcd by Honcger ct al. [8]. Reactions wcrc curried out for 30 
min at 37°C with stirring. The supernatant wits rapidly uspirutcd and 
the rndiolubclcd immunoprccipitatcs were colkctcd and mixed with 3x 
conccntrutcd SDS gel-loading butI& and resolved on 7.5% SDS po- 
lyacryi~tnridc gel clcctrophorcsis. Itnn~unoblot analysis WBS perrormcd 
cssc~~~hlly ;IS previously dcscribrd [9] cxcep~ that cells wre solubilizcd 
in Iysis bulkr A. Binding cxpcriments wcrc pctformcd according to 
Lax Cl al. [9]. 
3. RESULTS 
HER i4 c~!!s F~K treat& with I mivl diamidc and 
incubated for 30 min at 25OC. PTPase activity was in- 
hibited by I mM diamide as shown on SDS-gel electro- 
phoresis (Fig. I, lane 4). Treatment of cells with 83 nM 
EGF had no apparent effect on PTPase activity (Fig. 1, 
lane 3). Pre-incubation of cells with 83 nM EGF fol- 
lowed by incubation with 1 mM diamide (Fig. I, lane 
5) or pre-incubation of cells with I mM diamide fol- 
lowed by incubation with 83 nM EGF (Fig. 1, lane 6) 
showed an increase in PTPase activity when compared 
to I mM diamide (Fig. 1, lane 4), with the increase 
greatest in the latter situation (Fig. I, lane 6). The addi- 
tion of 2-mcrcapto~thanol to lysatcs of cells pretreated 
with I mM diamide (Fig. 2, lane 5) resulted in a partial 
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Fig. I. Effect ordiamidc on PTPasc activity in HER 14 cells. HER 14 
cells were incubatd Ibr 30 min at 25°C in DMEM conlaining 20 mM 
HEPES and IQ bovine strum albumiu. PTPasc aclivity was assayed 
in the supcrnatants as dcscribcd in Mawrials and Xlcthods. (Lane I) 
phosphorylatcd reccplor. 110 Iysatc added; (lane 2) phosphorylatcd 
receptor plus Iysatc; (lane 3) as 2 with 83 nM EGF: (lane 4) as 2 with 
I mM diamidc; (lane 5) us 2 wi\h 83 nM EGF iollowed by I mM 
diamidc added al 5 min; (lane 6) as 2 with I mM diamidc followed by 
83 nM EGF added at 25 min. 
reversion of the inhibitory effect of 1 mM diamide (Fig. 
2, lane 3) on PTPase activity. Incubation of 1 mM dia- 
mide with cell extracts also showed inhibition of PTPase 
activity (data not shown). 
The effect of diamide on autophosphorylation of the 
EGF-receptor as well as binding of EGF to its receptor 
was investigated. Diamide at 1 mM did not stimulate 
autophosphorylation of the EGF-receptor as revealed 
by immunoblot analysis (Fig. 3. lane 3). The addition 
of EGF to diamide-treated cells [Fig. 3, lanes 4 and 5) 
showed tyrosine kinase activity similar to EGF (Fig. 3, 
lane 2). Furthermore, billding of EGF LO its receptor 
was no: impaired by treatment of cells with diamide 
(data not shown). 
4. DISCUSSION 
Diamide can inhibit the activity of PTPases which 
regulate tyrosine kinasc activity of the EGF receptor. 
This inhibition probably occurs by the oxidation of sulf- 
1 2 3 4 5 
. 
Fig. 2. Effect of 2-mcrcep~oc\hunol on PTPasc activity in HER I4 
cells. Conditions and assay wcrc the same as in Fig. I. (Lane I) 
phosphorylutcd rcccp[or, no Iysalc added; (lane 2) phnsphorylakd 
rcccplor plus lysutc; (law 3) as 2 with I mM diamidc; (lane 4) as 2 with 
2 mM Znicrcaptoclhanol; (I;lnc 5) ;1s 2 with 1 mM diamidc plus 2 mbl 
?- nicrcuploclhanol. 
Fig. 3. El’fcct of diamide on autophosphorylalion of the EGF-rcccplor 
in HER I4 cells. Con$tions wcrc the same as in Fig. I. Immunoprc- 
cipiiation of the EGF-rcccplor by mAb I08 was followed by an immu- 
noblot analysis oTthc prccipilalcd receptor with anti-phospholyrosinc 
antibodies. (Lane I) control; (lane 2) 83 nM EGF; (lane 3) I mM 
diamidc; (lane 4) 83 nX1 EGF Tollowcd by I mM diamidc added al 5 
min: (lane 5) I mM diamidc followed by 83 nM EGF added al 25 min. 
hydryl groups on the enzyme and is consistent with the 
evidence that its activity is dependent on specific cys- 
teine residues in their catalytic domains [j]. The finding 
that 2-mercaptoethanol reverses the inhibition by dia- 
mide provides evidence in favor of oxidized sullhydryl 
groups as being responsible for the loss of PTPasc activ- 
ity, and suggests that oxidation-reduction processes 
may be of importance in the regulation of protein phos- 
phorylation in receptor signal pathways. An oxidation- 
reduction ljroccss was rcccntly demonstra!ed for main- 
taining the activity of a protein tyrosine kinasc in the 
endoplasmic reticulum of a B lymphocyte cell line [IO]. 
The attenuation of the diamide-inhibited PTPase ac- 
tivity by EGF indicates that activation of the EGF re- 
ceptor could have consequences on PTPase activity. 
The underlying mechanism is not apparent, but EGF 
must inlluence processes that regulate the reduction of 
critical sulfhydryl groups affecting PTPase activity. 
Consistent with this idea is the observation of increased 
production of reducing equivalents by EGF activation 
of the hexose monophosphate shunt in rat kidney cells 
[l I]. That binding of EGF to its receptor was not af- 
fected by diamide suggests that the sulfhydryl oxidant 
modulates PTPase activity with some specificity. 
An increase in EGF receptor phosphorylation was 
not observed in cells treated with diamide and EGF. 
This indicates that turnover of tyrosine kinasc phos- 
phorylation is not a rate-limiting step in the signal 
transduction pathway of EGF. A similar pattern was 
observed for the insulin receptor, where phenylarsine 
oxide, a dithiol complexing agent that inhibits PTPase, 
did not enhance phosphorylation of the tyrosine kinasc 
activity of the b-subunit of the insulin receptor, but 
activated tyrosine phosphorylation of a I5 kDa (~~15) 
protein in adipocytes [12]. 
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